Peripheral Myelin Protein 22 (PMP22) Gene Mutation Analysis
The PMP22 gene is located in the short (p) arm of chromosome 17 at position 12 and encodes growth arrest-specific protein 3 (GAS-3), also called peripheral myelin protein 22 (PMP22). This protein is primarily expressed in the compact myelin of the peripheral nervous system, most notably in Schwann cells, where it constitutes approximately 5% of the total protein. It has a crucial role in the development and maintenance of myelin and also plays a role in proliferation and differentiation of Schwann cells. PMP22 protein is particularly important in protecting nerves from physical pressure, helping them restore their structure after being pinched or compressed. Mutations in PMP22 gene are associated with a variety of neuropathies, such as Charcot–Marie–Tooth type 1A (CMT1A), Dejerine-Sottas disease, and hereditary neuropathy with liability to pressure palsy.
CMT1A is aa autosomal dominantly inherited sensory motor neuropathy and is caused by duplication of the PMP22 gene in 80% of cases and the remaining 20% have point mutation in PMP22. The extra gene leads to an overproduction of PMP22 protein. The buildup of the protein may impair the formation of myelin and disrupt other Schwann cell activities, leading to instability and demyelination. Loss of myelin reduces the ability of peripheral nerves to activate muscles used for movement or relay information from sensory cells back to the brain. Affected individuals may experience atrophy of the muscles of the lower legs and hands and decreased sensitivity to touch, heat, and cold, which starts during adolescence.
Some mutations in the PMP22 gene cause a severe form of Charcot-Marie-Tooth disease sometimes referred to as Dejerine-Sottas disease or type 3 Charcot-Marie-Tooth diseases. This disorder starts in infancy and cause muscle weakness and atrophy and delayed development of motor skills such as walking. The mutations that cause this form of Charcot-Marie-Tooth disease are thought to reduce the amount of functional PMP22 protein in cells.
Hereditary neuropathy with liability to pressure palsy (HNPP) is an autosomal dominant disorder that produces episodic, recurrent focal sensory motor neuropathy. It is due to deletion of one copy of the PMP22 gene which reduces the amount of PMP22 protein by approximately 50%. This disorder is characterized by recurrent episodes of numbness, tingling, or loss of muscle function, usually triggered by pressure on a nerve in an arm or leg. This disorder can also be caused by PMP22 gene mutations that change single amino acids in the PMP22 protein or that lead to production of an abnormally small protein that is rapidly broken down. Lack of PMP22 protein may affect the structure of the myelin covering, impairing the transmission of nerve impulses. The common symptoms of focal numbness, muscular weakness and atrophy usually begin during adolescence.
- As an aid in diagnosis of a suspected inherited peripheral neuropathy i.e. Charcot-Marie-Tooth neuropathy (CMT) and hereditary neuropathy with liability to pressure palsies (HNPP)
- For preconceptional planning for potentially at-risk individuals
- For preimplantation embryonic testing in potentially at-risk individual
- Detection of any or pathogenic variant (deletion or duplication) in PMP22 gene is consistent with a diagnosis of hereditary neuropathy with liability to pressure palsies.
- Variants may be benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants.
Negative for mutations analyzed (No pathogenic variant or mutation detected)
Whole blood (EDTA), Buccal swab.
Stability
- Ambient: 3-5 days
- Refrigerated: 7-14 days
- Frozen: Unacceptable
- Mol Neurobiol. 2013; 47: 673–698. [PMID: 23224996]
- Curr Genomics. 2018;19: 412-419. [PMID: 30258273]
- Ann Neurol. 2014;75: 255-65. [PMID: 24339129]
- Sci Rep. 2014;4: 7286. [PMID: 25446378]
- BMC Med Genet. 2013;14: 94. [PMID: 24053775]
- Bell, C., & Haites, N. (1997). The Peripheral Neuropathies and Their Molecular Genetics. Advances in Genetics, 1–44. doi:10.1016/s0065-2660(08)60306-5
- GeneReviews® [Internet]. Available at https://www.ncbi.nlm.nih.gov/books/NBK1358/
- Genetics Home Reference. Available at: https://ghr.nlm.nih.gov/gene/PMP22#